- Total raised
- Public
- Stage
- Public
- Last round
- May 2025
- Team size
- 201-500
- Founded
- 2008
- HQ
- Rockville
About REGENXBIO
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Open roles · 5
- Open
Associate Director, Rare Disease Product Marketing
Rockville, Maryland · hybrid · $160k–215k
- Open
Associate Director, Data & Information Architecture
Virginia · remote
- Open
Senior Medical Science Liaison - DMD/Neuromuscular (South)
Maryland · remote · $170k–230k
- Open
Senior Medical Science Liaison - DMD/Neuromuscular (Northeast)
Maryland · remote · $170k–230k
- Open
Senior Medical Science Liaison - DMD/Neuromuscular (West Coast)
California · remote · $170k–230k
Location
More startups in Rockville
Ascend Advanced Therapies
Rockville
Rockville-based · biotechnology research.
Maxim Biomedical
Rockville
Rockville-based · biotechnology research.
MaxCyte
Rockville
MaxCyte specializes in cell modification technologies that enable the discovery, development, and manufacture of various classes.
Hillcrest Labs
Rockville
Rockville-based.
CloudBolt
Rockville
Rockville-based.
Quantum Space
Rockville
Rockville-based.